免疫疗法对中枢神经系统瘤的承诺
Jasia Mahdi1, Vrunda Trivedi2,3, Michelle Monje4,5,6,7,8
1Division of Neurology and Developmental Neurosciences, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Nature reviews. Immunology
|October 6, 2025
概括
免疫疗法通过利用神经系统和免疫系统的连接来治疗侵略性脑瘤具有前途. 本综述涵盖了各种免疫疗法结果和潜在的神经系统副作用.
科学领域:
- 神经免疫学 神经免疫学
- 在瘤学瘤学.
- 癌症免疫疗法癌症免疫疗法
背景情况:
- 神经系统和免疫系统是双向通信的.
- 对于攻击性中枢神经系统 (CNS) 瘤,目前的有效治疗方法有限.
- 免疫疗法是中枢神经系统恶性瘤的一个有希望的策略.
研究的目的:
- 审查中枢神经系统瘤免疫疗法背后的神经免疫连接.
- 总结初级中枢神经系统癌症的免疫治疗结果.
- 讨论中枢神经系统癌症免疫疗法的神经学副作用.
主要方法:
- 对中枢神经系统瘤免疫治疗的临床前和临床研究的综述.
- 对仿真抗原受体T细胞疗法,瘤病毒,癌症疫苗和免疫检查点抑制剂的数据分析.
- 检查与这些治疗相关的神经症状.
主要成果:
- 免疫疗法在治疗高度质瘤,耐火胚胎脑瘤和初级中枢神经系统淋巴瘤方面表现出潜力.
- 针对中枢神经系统癌症,正在探索各种免疫治疗方法.
- 这些治疗可以引起神经系统的副作用.
结论:
- 神经系统和免疫系统之间的相互作用为中枢神经系统癌症的免疫疗法提供了理由.
- 免疫疗法为挑战大脑瘤提供了新的治疗途径.
- 了解和管理潜在的神经毒性对于有效的中枢神经系统癌症免疫治疗至关重要.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
960
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
960
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K


